Primary information |
---|
sequence ID | Seq_216 |
Peptide sequence | AEDHFSVIDFNQNIR |
CancerPDF_ID | CancerPDF_ID766, CancerPDF_ID819, CancerPDF_ID1792, |
PMID | 19795908,19795908,21136997 |
Protein Name | Inter-alpha-trypsin inhibitor heavy chain H2,Inter-alpha-trypsin inhibitor heavy chain H2,Inter-alpha-trypsin inhibitor heavy chain H2 |
UniprotKB Entry Name | ITIH2_HUMAN,ITIH4_HUMAN,ITIH2_HUMAN |
Fluid | Plasma,Plasma,Serum |
M/Z | 602.28,602.28,1803.85401 |
Charge | 3,2,1 |
Mass (in Da) | NA,NA,NA |
fdr | NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,LC-MS |
Peptide Identification technique | MALDI-TOF/TOF,MALDI-TOF/TOF,LC-MS-MS/MS |
Quantification Technique | LC-MRM (multiple reaction monitoring),LC-MRM (multiple reaction monitoring),LC-ESI-MS |
Labelled/Label Free | Labelled,Labelled,Label Free |
FDR | less than 7%,less than 7%,NA |
CancerPDF_ID | CancerPDF_ID766, CancerPDF_ID819, CancerPDF_ID1792, |
p-Value | NA,NA,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01) |
Length | 15,15,15 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer |
Database | NCBI refseq Protein Database,NCBI refseq Protein Database,SwissProt Database |
Modification | NA,NA,NA |
Number of Patients | "41 normal, 23 patients","42 normal, 23 patients",30 patients and 30 healthy controls |
Regulation | NA,NA,NA |
Validation | NA,NA,Leave One out Cross validation |
Sensitivity | NA,NA,NA |
Specificity | NA,NA,NA |
Accuracy | NA,NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | |